A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease

Circulation Journal

Volumn 74, Issue 4, 2010, Pages 671-678

  Yamagata, Ken ichirou ^a   Kataoka, Yu ^a   Kokubu, Nobuaki ^a   Kasahara, Yoichiro ^a   Abe, Mitsuru ^a   Nakajima, Hiroyuki ^a   Kobayashi, Junjiro ^a   Otsuka, Yoritaka ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Coronary artery disease; Diabetes mellitus; Off pump coronary artery bypass grafting; Sirolimuseluting stent

Indexed keywords

GLUCOSE; RAPAMYCIN;

AGED; ANGIOGRAPHY; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; STROKE; TREATMENT OUTCOME;

EID: 77950640712     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0736     Document Type: Article

References (36)

1. Grundy SM, D'Agostino Sr RB, Mosca L, Burke GL, Wilson PW, Rader DJ, et al. Cardiovascular risk assessment based on US cohort studies: Findings from a National Heart, Lung, and Blood Institute workshop. Circulation 2001; 104: 491-496.
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
3. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in type II diabetes: Angiographic findings and clinical outcome. Diabetologia 2000; 43: 632-641.
4. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, et al. Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study. J Am Coll Cardiol 2002; 40: 946-953.
5. Ledru F, Ducimetière P, Battaglia S, Courbon D, Beverelli F, Guize L, et al. New diagnostic criteria for diabetes and coronary artery disease: Insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543-1550.
6. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980; 69: 498-506.
7. Kataoka Y, Yasuda S, Otsuka Y, Morii I, Kawamura A, Miyazaki S. Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance. Diabetes Care 2005; 28: 2217-2222.
8. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-225.
9. King SB 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med 1994; 331: 1044-1050.
10. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
11. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al; RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
12. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
13. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: The DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008; 51: 2212-2219.
14. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
15. Al-Ruzzeh S, George S, Bustami M, Wray J, Ilsley C, Athanasiou T, et al. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: Randomized controlled trial. BMJ 2006; 332: 1365.
16. Hannan EL, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT, et al. Off-pump versus on-pump coronary artery bypass graft surgery: Differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 2007; 116: 1145-1152.
17. Kim WS, Lee J, Lee YT, Sung K, Yang JH, Jun TG, et al. Total arterial revascularization in triple-vessel disease with off-pump and aortic no-touch technique. Ann Thorac Surg 2008; 86: 1861-1865.
18. Navia D, Vrancic M, Vaccarino G, Piccinini F, Raich H, Florit S, et al. Total arterial off-pump coronary revascularization using bilateral internal thoracic arteries in triple-vessel disease: Surgical technique and clinical outcomes. Ann Thorac Surg 2008; 86: 524-530.
19. Yan Q, Changsheng M, Shaoping N, Xiaohui L, Junping K, Qiang L, et al. Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery. Circ J 2009; 73: 1848-1855.
20. Cheng CI, Lee FY, Chang JP, Hsueh SK, Hsieh YK, Fang CY, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: Coronary stenting vs coronary artery bypass grafting. Circ J 2009; 73: 705-712.
21. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
22. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
23. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, et al; ARTS-II Investigators. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 2008; 52: 1957-1967.
24. Briguori C, Condorelli G, Airoldi F, Focaccio A, D'Andrea D, Cannavale M, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007; 99: 779-784.
25. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 1305-1310.
26. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al; SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004; 43: 1959-1963.
27. Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008; 29: 1851-1857.
28. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
29. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
30. Kon ZN, Kwon MH, Collins MJ, Kallam S, Sangrampurkar R, Ozeki T, et al. Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers. Innovations Phila Pa 2006; 1: 232-238.
31. Untch BR, Jeske WP, Schwartz J, Botkin S, Prechel M, Walenga JM, et al. Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass grafting. Clin Appl Thromb Hemost 2008; 14: 141-148.
32. Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxeleluting and bare metal stent implantation. Circulation 2007; 115: 2842-2847.
33. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
34. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
35. King SB 3rd, Barnhart HX, Kosinski AS, Weintraub WS, Lembo NJ, Petersen JY, et al. Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol 1997; 79: 1453-1459.
36. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J 2008; 155: 215-223.